Stone Summit Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Stone Summit Wealth's GILD Position: Q1 2026 in Review
Stone Summit Wealth reduced its Gilead Sciences (GILD) stake by 4% in Q1 2026, selling an estimated $184K and leaving 31,246 shares worth $4.35M. The position accounts for 1.21% of the portfolio, ranked #25.
Stone Summit Wealth first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Stone Summit Wealth held 31,246 shares of Gilead Sciences worth $4.35M as of Q1 2026.
- Stone Summit Wealth sold 1,311 Gilead Sciences shares in Q1 2026, an estimated $184K.
- Gilead Sciences made up 1.21% of Stone Summit Wealth's portfolio in Q1 2026, its #25 holding.
- Stone Summit Wealth first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Stone Summit Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.